Table 2.

Relationship between the clinical features and OGDHL expression in liver cancer patients.

Clinical characteristics	Variable	No. of patients	OGDHL expression				χ 2	P value
			High	%	Low	%
Age	<55	117	74	27.41	43	42.16	6.802	0.009
	≥55	255	196	72.59	59	57.84
Gender	Female	121	86	31.85	35	33.98	0.072	0.788
	Male	252	184	68.15	68	66.02
Histological type	Fibrolamellar carcinoma	3	3	1.11	0	0	1.809	0.617
	Hepatocellular carcinoma	363	261	96.67	102	99.03
	Hepatocholangiocarcinoma (mixed)	7	6	2.22	1	0.97
Histologic grade	G1	55	41	15.47	14	13.59	25.673	0.000
	G2	178	147	55.47	31	30.1
	G3	123	69	26.04	54	52.43
	G4	12	8	3.02	4	3.88
Stage	I	172	135	54	37	37.37	10.116	0.015
	II	87	60	24	27	27.27
	III	85	51	20.4	34	34.34
	IV	5	4	1.6	1	1.01
T classification	T1	182	144	53.73	38	36.89	10.765	0.020
	T2	95	64	23.88	31	30.1
	T3	80	49	18.28	31	30.1
	T4	13	10	3.73	3	2.91
	TX	1	1	0.37	0	0
N classification	N0	253	178	65.93	75	73.53	3.519	0.149
	N1	4	2	0.74	2	1.96
	NX	115	90	33.33	25	24.51
M classification	M0	267	186	68.89	81	78.64	3.523	0.156
	M1	4	3	1.11	1	0.97
	MX	102	81	30	21	20.39
Radiation therapy	No	340	245	97.22	95	98.96	0.320	0.572
	Yes	8	7	2.78	1	1.04
Residual tumor	R0	326	239	90.53	87	85.29	4.018	0.245
	R1	17	12	4.55	5	4.9
	R2	1	1	0.38	0	0
	RX	22	12	4.55	10	9.8
Vital status	Deceased	130	85	31.48	45	43.69	4.371	0.037
	Living	243	185	68.52	58	56.31